New Therapeutic option for rapid and “short-term” treatment of supraventricular tachycardia AOP Health strives to offer solutions for patients with rare diseases or in critical care. Therefore, this ...

“Rapiblyk TM approval in the US represents an important milestone for patients experiencing supraventricular tachycardia, including atrial fibrillation and atrial flutter, who need rapid and ...